These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

292 related items for PubMed ID: 20739500

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Evaluation of immunogenicity and efficacy of anthrax vaccine adsorbed for postexposure prophylaxis.
    Ionin B, Hopkins RJ, Pleune B, Sivko GS, Reid FM, Clement KH, Rudge TL, Stark GV, Innes A, Sari S, Guina T, Howard C, Smith J, Swoboda ML, Vert-Wong E, Johnson V, Nabors GS, Skiadopoulos MH.
    Clin Vaccine Immunol; 2013 Jul; 20(7):1016-26. PubMed ID: 23658392
    [Abstract] [Full Text] [Related]

  • 23. Comparative performance of a licensed anthrax vaccine versus electroporation based delivery of a PA encoding DNA vaccine in rhesus macaques.
    Livingston BD, Little SF, Luxembourg A, Ellefsen B, Hannaman D.
    Vaccine; 2010 Jan 22; 28(4):1056-61. PubMed ID: 19896452
    [Abstract] [Full Text] [Related]

  • 24. Domain specificity of the human antibody response to Bacillus anthracis protective antigen.
    Reason DC, Ullal A, Liberato J, Sun J, Keitel W, Zhou J.
    Vaccine; 2008 Jul 29; 26(32):4041-7. PubMed ID: 18565627
    [Abstract] [Full Text] [Related]

  • 25. Anthrax vaccination induced anti-lethal factor IgG: fine specificity and neutralizing capacity.
    Crowe SR, Garman L, Engler RJ, Farris AD, Ballard JD, Harley JB, James JA.
    Vaccine; 2011 May 09; 29(20):3670-8. PubMed ID: 21420416
    [Abstract] [Full Text] [Related]

  • 26. CD1d-dependent B-cell help by NK-like T cells leads to enhanced and sustained production of Bacillus anthracis lethal toxin-neutralizing antibodies.
    Devera TS, Aye LM, Lang GA, Joshi SK, Ballard JD, Lang ML.
    Infect Immun; 2010 Apr 09; 78(4):1610-7. PubMed ID: 20123711
    [Abstract] [Full Text] [Related]

  • 27. Binding of the von Willebrand Factor A Domain of Capillary Morphogenesis Protein 2 to Anthrax Protective Antigen Vaccine Reduces Immunogenicity in Mice.
    de Oliveira FFM, Mamillapalli S, Gonti S, Brey RN, Li H, Schiffer J, Casadevall A, Bann JG.
    mSphere; 2020 Jan 15; 5(1):. PubMed ID: 31941807
    [Abstract] [Full Text] [Related]

  • 28. Killed but metabolically active Bacillus anthracis vaccines induce broad and protective immunity against anthrax.
    Skoble J, Beaber JW, Gao Y, Lovchik JA, Sower LE, Liu W, Luckett W, Peterson JW, Calendar R, Portnoy DA, Lyons CR, Dubensky TW.
    Infect Immun; 2009 Apr 15; 77(4):1649-63. PubMed ID: 19168734
    [Abstract] [Full Text] [Related]

  • 29. Comparison of three anthrax toxin neutralization assays.
    Ngundi MM, Meade BD, Lin TL, Tang WJ, Burns DL.
    Clin Vaccine Immunol; 2010 Jun 15; 17(6):895-903. PubMed ID: 20375243
    [Abstract] [Full Text] [Related]

  • 30. Immunogenicity of recombinant protective antigen and efficacy against aerosol challenge with anthrax.
    Williamson ED, Hodgson I, Walker NJ, Topping AW, Duchars MG, Mott JM, Estep J, Lebutt C, Flick-Smith HC, Jones HE, Li H, Quinn CP.
    Infect Immun; 2005 Sep 15; 73(9):5978-87. PubMed ID: 16113318
    [Abstract] [Full Text] [Related]

  • 31. Development of a competitive enzyme linked immunosorbent assay to identify epitope specific antibodies in recipients of the U.S. licensed anthrax vaccine.
    Gubbins MJ, Schmidt L, Tsang RS, Berry JD, Kabani A, Stewart DI.
    J Immunoassay Immunochem; 2007 Sep 15; 28(3):213-25. PubMed ID: 17613668
    [Abstract] [Full Text] [Related]

  • 32. A heterodimer of a VHH (variable domains of camelid heavy chain-only) antibody that inhibits anthrax toxin cell binding linked to a VHH antibody that blocks oligomer formation is highly protective in an anthrax spore challenge model.
    Moayeri M, Leysath CE, Tremblay JM, Vrentas C, Crown D, Leppla SH, Shoemaker CB.
    J Biol Chem; 2015 Mar 06; 290(10):6584-95. PubMed ID: 25564615
    [Abstract] [Full Text] [Related]

  • 33. Development of a novel multiepitope chimeric vaccine against anthrax.
    Aggarwal S, Somani VK, Gupta S, Garg R, Bhatnagar R.
    Med Microbiol Immunol; 2019 Apr 06; 208(2):185-195. PubMed ID: 30671633
    [Abstract] [Full Text] [Related]

  • 34. Anthrax vaccine antigen-adjuvant formulations completely protect New Zealand white rabbits against challenge with Bacillus anthracis Ames strain spores.
    Peachman KK, Li Q, Matyas GR, Shivachandra SB, Lovchik J, Lyons RC, Alving CR, Rao VB, Rao M.
    Clin Vaccine Immunol; 2012 Jan 06; 19(1):11-6. PubMed ID: 22089245
    [Abstract] [Full Text] [Related]

  • 35. Human monoclonal antibodies generated following vaccination with AVA provide neutralization by blocking furin cleavage but not by preventing oligomerization.
    Smith K, Crowe SR, Garman L, Guthridge CJ, Muther JJ, McKee E, Zheng NY, Farris AD, Guthridge JM, Wilson PC, James JA.
    Vaccine; 2012 Jun 13; 30(28):4276-83. PubMed ID: 22425791
    [Abstract] [Full Text] [Related]

  • 36. Comparative analysis of the immunologic response induced by the Sterne 34F2 live spore Bacillus anthracis vaccine in a ruminant model.
    Ndumnego OC, Köhler SM, Crafford J, van Heerden H, Beyer W.
    Vet Immunol Immunopathol; 2016 Oct 01; 178():14-21. PubMed ID: 27496738
    [Abstract] [Full Text] [Related]

  • 37. Selection and evaluation of the immunogenicity of protective antigen mutants as anthrax vaccine candidates.
    Yan M, Roehrl MH, Basar E, Wang JY.
    Vaccine; 2008 Feb 13; 26(7):947-55. PubMed ID: 18192092
    [Abstract] [Full Text] [Related]

  • 38. In vitro correlate of immunity in a rabbit model of inhalational anthrax.
    Pitt ML, Little SF, Ivins BE, Fellows P, Barth J, Hewetson J, Gibbs P, Dertzbaugh M, Friedlander AM.
    Vaccine; 2001 Sep 14; 19(32):4768-73. PubMed ID: 11535328
    [Abstract] [Full Text] [Related]

  • 39. Anthrax protective antigen delivered by Salmonella enterica serovar Typhi Ty21a protects mice from a lethal anthrax spore challenge.
    Osorio M, Wu Y, Singh S, Merkel TJ, Bhattacharyya S, Blake MS, Kopecko DJ.
    Infect Immun; 2009 Apr 14; 77(4):1475-82. PubMed ID: 19179420
    [Abstract] [Full Text] [Related]

  • 40. A plant based protective antigen [PA(dIV)] vaccine expressed in chloroplasts demonstrates protective immunity in mice against anthrax.
    Gorantala J, Grover S, Goel D, Rahi A, Jayadev Magani SK, Chandra S, Bhatnagar R.
    Vaccine; 2011 Jun 15; 29(27):4521-33. PubMed ID: 21504775
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 15.